col0,col1,col2,col3,col4,col5,col6,col7
adalimumab,Humira,anti-inflammatory agent,Adalimumab,2.9,ulcerative colitis,Australian pregnancy category C,biopharmaceutical
infliximab,Flixabi,dermatologic drug,Infliximab,3.75,ulcerative colitis,Australian pregnancy category C,monoclonal antibody
adalimumab,Humira,anti-inflammatory agent,Adalimumab,2.9,ulcerative colitis,Australian pregnancy category C,monoclonal antibody
infliximab,Flixabi,dermatologic drug,Infliximab,3.75,ulcerative colitis,Australian pregnancy category C,medication
adalimumab,Humira,immunologic factor,Adalimumab,2.9,ulcerative colitis,Australian pregnancy category C,monoclonal antibody
infliximab,Flixabi,dermatologic drug,Infliximab,3.75,ulcerative colitis,Australian pregnancy category C,chemical compound
